v3.25.2
Revenues (Tables)
 6 Months Ended
Jun. 30, 2025
Revenue from Contract with Customer [Abstract]  
Disaggregation of Revenue by Product and Geographic Area
Revenues by Product Line. The following table represents total net revenues by product line (in thousands):
For the Three Months Ended June 30,For the Six Months Ended June 30,
2025202420252024
HIV$14,398 $13,652 $27,298 $27,032 
Sample Management Solutions (1)
9,855 12,609 18,965 23,431 
HCV4,126 4,734 8,459 7,734 
Risk Assessment Testing (2)
446 2,308 1,866 4,352 
Other product and services revenues (3)
994 897 1,767 1,429 
COVID-19 (4)
28 18,939 489 42,067 
Molecular Services— 810 — 1,683 
Net product and services revenues$29,847 $53,949 $58,844 $107,728 
Non-product and services revenues (5)
1,395 386 2,329 739 
Net revenues$31,242 $54,335 $61,173 $108,467 
(1)Includes Genomics, Microbiome and Colli-Pee® product revenues.
(2)Includes substance abuse testing product revenues.
(3)Includes Syphilis revenues.
(4)Includes COVID-19 Diagnostics and COVID-19 Sample Management Solutions revenues.
(5)Includes funded research and development contracts, royalty income and grant revenues.
Revenues by Geographic Area. The following table represents total net revenues by geographic area, based on the location of the customer (in thousands):
For the Three Months Ended June 30,For the Six Months Ended June 30,
2025202420252024
United States$19,852 $44,386 $40,187 $89,597 
Africa8,027 6,366 15,216 12,070 
Europe2,117 2,164 3,754 3,766 
Other regions1,246 1,419 2,016 3,034 
$31,242 $54,335 $61,173 $108,467 
Schedules of Concentration of Risk, by Risk Factor The following table represents customer concentration risk:
For the Three Months Ended June 30,For the Six Months Ended June 30,
2025202420252024
Net Revenues
Non-commercial customer N/A33%N/A37%
June 30,December 31,
20252024
Accounts Receivable
Commercial customer19%10%
Contract with Customer, Contract Asset, Contract Liability, and Receivable
The following table represents deferred revenue recognized:
For the Three Months Ended June 30,For the Six Months Ended June 30,
Deferred Revenue Recognized2025202420252024
Accrued at beginning of period$974 $774 $1,461 $1,194